High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial. (2017)

First Author: Boeree MJ

Attributed to: Tuberculosis Treatment Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(16)30274-2

PubMed Identifier: 28100438

Publication URI: http://europepmc.org/abstract/MED/28100438

Type: Journal Article/Review

Volume: 17

Parent Publication: The Lancet. Infectious diseases

Issue: 1

ISSN: 1473-3099